National HIV/AIDS Program | ![](images/global/clr_pxl.gif) | | ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | Antiretroviral Therapy![](images/global/clr_pxl.gif) | VA Policies & Notifications | ![](images/global/clr_pxl.gif) | | ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | In-Depth | ![](images/global/clr_pxl.gif) | - Initiating Antiretroviral Therapy
E.M. Kojic, MD, and Charles C.J. Carpenter, MD Focuses on when to
initiate ART in individuals with established HIV infection, and which
regimens are effective for the initial treatment of HIV infection
- Changing Antiretroviral Therapy: Why, When, and How
Timothy Wilkin MD, MPH, Marshall Glesby, MD, MPH, and Roy M. Gulick,
MD, MPH Reviews circumstances related to changing ART and provides
clinical evidence and strategies for changing therapy
- Genotypic Testing for HIV-1 Drug Resistance
Robert W. Shafer, MD Discusses evolution of drug resistance,
resistance to specific types of drugs, identifying and characterizing
mutations, and limitations of testing
- Metabolic Complications of HIV Therapy
Dominic C. Chow, MD, Larry J. Day, MD, and Cecilia M. Shikuma,
MD Discusses abnormalities such as impaired glucose metabolism and
insulin resistance, lactic acidosis, osteopenia, and dyslipidemia
- Adherence to HIV Antiretroviral Therapy
Edward L. Machtinger, MD, and David R. Bangsberg, MD Reviews the
current understanding of antiretroviral adherence, with a focus on
describing the clinical implications of nonadherence and practical
strategies for assessing and improving adherence
- Assays for Antiretroviral Resistance
Robert W. Shafer, MD Covers genotypic and phenotypic resistance
testing, drug resistance interpretation, and limitations of testing
- Clinical Implications of Immune Reconstitution in AIDS
Mark A. Jacobson, MD Discusses beneficial immune reconstitution as well as troublesome immune reconstitution disease (IRD) syndromes
| ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | Research Summaries | ![](images/global/clr_pxl.gif) | - HIV Meds Quarterly
Brief updates and analysis of new findings related to common therapies used by HIV clinicians
| ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | Provider Education and Training | ![](images/global/clr_pxl.gif) | | ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | Clinician Tools | ![](images/global/clr_pxl.gif) | - The Image Library
Images of clinical symptoms of HIV, including dermatological,
pulmonary, ophthalmic, and oral manifestations
| ![](images/global/clr_pxl.gif) |
![](images/global/clr_pxl.gif) | ![](images/global/clr_pxl.gif) | |
![](images/global/clr_pxl.gif) | ![](images/global/clr_pxl.gif) | The appearance of external hyperlinks does not constitute endorsement by
the Department of Veterans Affairs of the linked Web sites, or the information,
products or services contained therein. | ![](images/global/clr_pxl.gif) |
| | ![](images/global/clr_pxl.gif) |
| ![](images/global/clr_pxl.gif) |
| ![](images/global/clr_pxl.gif) | | ![](images/global/clr_pxl.gif) |
|
| | |
|
Reviewed/Updated Date: April 23, 2008 |
|